Table 6 Clinical outcomes following BT
From: Safety of delivering bronchial thermoplasty in two treatment sessions
Pre BT | 6 months post BT | p | |
|---|---|---|---|
Accelerated treatment (n = 15) | |||
ACQ | 3.5 (1.5) | 2.4 (1.6) | 0.005 |
SABA (puffs/day) | 12.0 (9) | 6.0 (8.5) | 0.006 |
Exacerbations per 6 months | 2.0 (4.4) | 0 (2.0) | 0.007 |
Prednisolone (mg/day) | 10.0 (25) | 7.5 (10) | 0.058 |
FEV1 (% predicted) | 45.9 (22.1) | 51.6 (40.6) | 0.008 |
Conventional treatment (n = 37) | |||
ACQ | 3.0 (1.5) | 1.6 (1.7) | 0.001 |
SABA (puffs/day) | 8.0 (14.0) | 1.0 (6.25) | 0.001 |
Exacerbations per 6 months | 2.0 (4.0) | 0.0 (1.5) | 0.001 |
Prednisolone (mg/day) | 5.0 (10) | 0 (7.5) | 0.015 |
FEV1 (% predicted) | 49.5 (23.2) | 51.6 (22.8) | 0.248 |